Natasha Qin

Company: Inxmed

Job title: Senior Director, Business Development

Seminars:

Analyzing the Benefits of First-in-Class Stroma Targeting ADC 11:30 am

Learn how high stroma is a key mechanism leading to resistance in hard-to-treat tumors Assess an innovative target that was identified on tumor stroma Discuss how a stroma-targeting ADC demonstrates strong in vivo efficacy and deepens responses of cancer cell targeting ADCRead more

day: Day One